Pharmafile Logo
Pharmafocus logo
Advanced Search

Novartis

Showing 8 posts of 818 posts found.

Novartis changes pharma management after weak third quarter

October 19, 2007
Sales and Marketing Novartis

Novartis has switched the heads of its consumer and pharmaceuticals divisions as part of a wider reorganisation of its pharma …

News

Indian court dismisses Novartis patent claim

August 8, 2007
Sales and Marketing India, Novartis

Novartis has failed in its challenge to India's intellectual property laws as part of its attempt to secure a patent …

News

Latest news from Datamonitor

June 22, 2007
Research and Development, Sales and Marketing NSCLC, Novartis, Pfizer

 Novartis receives FDA approval for blood pressure medicineNovartis has been granted final FDA approval for Exforge, its high blood pressure …

News

Lucentis approved in Europe

January 26, 2007
Sales and Marketing Lucentis, Novartis

European regulators have approved Novartis’ Lucentis, a new treatment for neovascular age-related macular degeneration, known as wet AMD.The company says …

News

New blindness treatment moves closer to market

November 28, 2006
Sales and Marketing AMD, Lucentis, Novartis

Patients suffering from the leading cause of blindness could soon benefit from a new treatment after it gained preliminary approval …

News

Novartis to be first pharma to conduct R&D in China

November 7, 2006
Research and Development Asia, China, Novartis, em

Novartis is to open a major, new pharmaceutical research and development centre in China, becoming the first company in the …

News

New Novartis blindness treatment filed in Europe

March 2, 2006
Sales and Marketing AMD, Lucentis, Novartis

Lucentis, a new treatment for neovascular age-related macular degeneration or ‘wet AMD’ has been submitted by Novartis to the European …

News

Next generation monoclonal antibodies to enter clinical trials in 2007

January 20, 2006
Research and Development Ablynx, Novartis

Novartis has signed a deal with Belgium biotech Ablynx to develop the next generation of monoclonal antibodies with clinical development …

News

Latest content

Ardena announces €20m expansion following first GMP approval

April 19, 2024

Roche’s Alecensa approved by FDA as lung cancer treatment

April 19, 2024

GSK shares results from phase 3 trial for gonorrhoea treatment

April 18, 2024

Eli Lilly’s tirzepatide demonstrates efficacy in reducing sleep apnoea severity

April 18, 2024

Medincell and AbbVie enter agreement for development of next-generation injectables

April 17, 2024